- Home
- / LogicBio Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
LogicBio Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$6.7
2024-10-29
Market Capitalization
$176.3 M
2024-10-29
Revenue
$5.4 M
FY, 2021
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|---|---|
| Revenue | 3.5M | 5.4M | ||||
| General and administrative expense | 1.4M | 2.3M | 6.9M | 10.4M | 12.2M | 16.2M |
| Operating expense total | 3.4M | 5.9M | 17.9M | 41.0M | 35.0M | |
| EBIT | (3.4M) | (5.9M) | (17.9M) | (41.0M) | (31.5M) | (39.0M) |
| EBIT margin, % | -912.3% | |||||
| Interest income | 54.0K | |||||
| Interest expense | 1.0K | 567.0K | 1.5M | 181.0K | 16.0K | |
| Pre tax profit | (3.4M) | (5.7M) | (17.6M) | (40.1M) | (32.4M) | (40.1M) |
| Income tax expense | 18.0K | 62.0K | 86.0K | 22.0K | 188.0K | (28.0K) |
| Net Income | (3.4M) | (5.8M) | (17.6M) | (40.1M) | (32.6M) | (40.0M) |